osteoporosis%20in%20women
OSTEOPOROSIS IN WOMEN
Osteoporosis is a progressive, systemic, skeletal disease characterized by decreased bone mass and microarchitectural deterioration of bone tissue leading to increased bone fragility and susceptibility to fractures.
The more risk factors (eg history of fracture, advanced age, comorbidities, etc) that are present, the greater the risk of fracture.

Osteoporosis in Women Drug Information

Drug Information

Indication: Osteoporosis in postmenopausal women at increased risk of fracture. Increases bone mineral density & reduc...

Indication: Osteoporosis in postmenopausal women & prevents fractures in men.

Indication: Prevention & treatment of Ca deficiency.

Indication: Postmenopausal osteoporosis, to reduce the risk of fractures.

Cebion Vitamin C + Calcium Effervescent Tablet
ascorbic acid + calcium carbonate

Indication: Health supplement.

D-Cure
vitamin D

Indication: Prevention & treatment of vit D deficiency. Adjunctive therapy to osteoporosis in patients w/ vit D defici...

Indication: Osteoporosis in postmenopausal women & men at increased risk of fracture. Osteoporosis associated w/ susta...

Indication: Complaints resulting from natural or artificial menopause. Prevention of osteoporosis in postmenopausal women ...

Indication: Hypercalcemia of malignancy. Prevention of skeletal-related events (pathological fractures, spinal compression...

1  /  5
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 6 days ago
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
6 days ago
Patients with psoriatic arthritis (PsA) often suffer from liver abnormalities, which are associated with higher body mass index (BMI), daily consumption of alcohol, more severe disease, and some therapies, according to a recent study.
Christina Lau, 4 days ago

Pembrolizumab in combination with chemotherapy significantly improves progression-free survival (PFS) vs chemotherapy alone in patients with previously untreated, locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC), results of the KEYNOTE-355 study have shown.

Pearl Toh, 25 Jun 2020
The type of face mask matters, in addition to sterilization method, in influencing subsequent filtration efficiency after sterilization process for reuse, a new study finds.